![Scott M. Plesha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott M. Plesha
Keine laufenden Positionen mehr
Vermögen: 671 663 $ am 31.08.2026
Profil
Scott M.
Plesha is currently Chief Executive Officer at LNHC, Inc. since 2023 and President, Chief Executive Officer & Director at Pelthos Therapeutics, Inc. starting in 2025.
Formerly, Mr. Plesha was Sales Manager-OClassen Dermatologics Division at Actavis, Inc. from 1998 to 2000, Senior Vice President-Sales Force & Training at Salix Pharmaceuticals Ltd. from 2011 to 2015, and President & Chief Commercial Officer at BioDelivery Sciences International, Inc. from 2018 to 2022.
Mr. Plesha completed undergraduate education at DePauw University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,8 % | 15.07.2026 | 27.893 ( 0,8 % ) | 671 663 $ | 31.08.2026 |
Aktive Positionen von Scott M. Plesha
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Scott M. Plesha
| Unternehmen | Position | Ende |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Präsident | 22.03.2022 |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 01.04.2015 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Vertrieb & Marketing | 01.09.2000 |
Ausbildung von Scott M. Plesha
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for the prevention and treatment of gastrointestinal diseases & disorders | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
DePauw University
 DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
